The President of the Russian Academy of Sciences spoke about the development of a new method for the treatment of glaucoma of the eye

Russia has developed the world's first microstent for surgical treatment of glaucoma, implanted in the eye tissue. This was announced on May 28 by Gennady Krasnikov, President of the Russian Academy of Sciences (RAS).

"For the first time in the world, a microstent made of shape—memory material has been developed for glaucoma surgery," Krasnikov said at the general meeting of the Russian Academy of Sciences, held in Moscow on May 28-30.

According to him, about 1.5 million people suffer from this disease in Russia alone. In glaucoma, the nerve fibers of the eye are destroyed and intraocular pressure increases.

The development of Russian scientists is embedded in the tissues of the eye, straightens out from a compressed state and supports the outflow of intraocular fluid to prevent an increase in pressure, Krasnikov explained.

It is reported that the microstent was developed by specialists of the M.M. Krasnov Scientific Research Institute of Eye Diseases.

Frost under the skin: Russia has come up with a painless cancer cryotherapy technique

The innovation will increase the effectiveness of destroying kidney tumors with low temperatures

On May 22, it became known that doctors of the Department of Hospital Therapy No. 1 at Sechenov University, together with scientists from the Center for Biopharmaceutical Technologies and Metabolic Analysis at the First Moscow State Medical University, have developed a new method for diagnosing chronic heart failure by analyzing the metabolic profile.

It is reported that determining the patient's metabolic profile and phenotype can help improve the treatment of chronic heart failure.